Saturday, September 5, 2026

Palantir and CrowdStrike Deploy NVIDIA Nemotron for Persistent AI Agents in Production

Palantir and CrowdStrike are adopting NVIDIA Nemotron to run long-running autonomous AI agents in production environments. The move marks a transition from single-query AI inference toward persistent agents operating continuously in enterprise financial and security systems. Palantir's AIP platform is expected to announce agent capabilities as a new revenue driver in Q2 or Q3 2026 earnings.

LM Salvado

June 7, 2026

Palantir and CrowdStrike Deploy NVIDIA Nemotron for Persistent AI Agents in Production
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Palantir and CrowdStrike are deploying NVIDIA Nemotron to power persistent, long-running AI agents in live production systems.1 The move signals a direct shift from traditional AI inference — single-request, single-response — toward autonomous agents that operate continuously over time.

Palantir's AIP platform serves hedge funds, banks, and government agencies. Adding persistent agent capabilities changes the platform's value proposition from a query tool to an always-on decision system.1 CrowdStrike's adoption follows a parallel logic: cybersecurity demands continuous monitoring, not intermittent lookups.

The distinction matters. Inference-based AI answers questions. Agentic AI acts — watching data streams, triggering responses, and updating its own state without waiting for a human prompt. In financial services and security operations, that difference is operationally significant.

Enterprise demand for AI-augmented compliance and fraud detection is rising.1 Both sectors require systems that flag anomalies in real time, maintain context across long timeframes, and operate within strict regulatory constraints. Persistent agents are better suited to these workloads than one-shot models.

Palantir's agent expansion is expected to appear in Q2 or Q3 2026 earnings guidance as a new revenue category.1 For investors tracking the company, watch for language around AIP agent seats, usage-based pricing, or agentic workflow licensing in upcoming calls.

NVIDIA's role here is hardware and model infrastructure. Nemotron is NVIDIA's family of enterprise-optimized language models. Its adoption by two production-scale enterprise platforms confirms that the agentic layer is moving from research demos to revenue-generating deployments.

The broader pattern: enterprise AI is graduating from pilots. Palantir and CrowdStrike are not experimenting — they are shipping agents into systems that manage real money and real threats. Other enterprise software vendors serving regulated industries will face pressure to follow.

In this story

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com